Hims & Hers (HIMS) Q3 2026 Earnings
GAAP net loss includes $35.4 million of acquisition, transaction, and investment earn-out costs, $3.8 million of restructuring charges, a $21.1 million gain from change in fair value of equity securities, a $3.8 million gain from change in fair value of liabilities, and a $13.2 million income tax benefit. The company reported Adjusted Net Income of $6.5 million ($6,471 thousand) but did not disclose an adjusted per-share figure.
How Did HIMS Stock React to Q3 2026 Earnings?
Did HIMS Beat Earnings? Q3 2026 Results
No. Hims & Hers reported Q3 2026 earnings of $-0.14 a share on Nov 9, 2026, missing the $0.06 consensus estimate by 348.7%. Revenue was $890.4M against a $892.8M estimate.
Hims & Hers Health delivered a mixed third quarter for 2026, posting revenue of $890.37 million, up 48.6% year over year but just shy of the $892.77 million consensus estimate, while its GAAP loss of $0.14 per diluted share missed the $0.06 analyst expectation by 348.67%, a result that had already attracted <a href="https://247wallst.com/investing/2026/11/09/live-will-hims-q3-earnings-tonight-spark-a-rebound-after-todays-10-selloff/">significant short-side attention</a> heading into the print. The headline loss reflects a quarter burdened by $35.42 million in acquisition and earn-out costs, $3.83 million in restructuring charges tied to the company's U.S. weight loss strategic shift, and $64.48 million in stock-based compensation, partially offset by a $21.11 million fair-value gain on equity securities and a $13.20 million tax benefit. Gross margin compressed sharply to 57% from 74% a year earlier as international expansion costs mounted, with Rest of the World revenue surging 321% to $233.28 million. Management tightened full-year revenue guidance to $3.13 billion to $3.15 billion while trimming Adjusted EBITDA guidance to $257 million to $277 million, saying intentionally paced marketing spend ahead of planned Q4 platform expansions positions the company well entering 2027.
- Revenue up 49% YoY, second consecutive quarter of acceleration
- International revenue up more than 300% YoY (Rest of World +321%)
- Domestic revenue up 21% YoY
- Subscribers grew 13% YoY to 2,788 thousand
- Monthly revenue per average subscriber up 30% to $105 from $81
- Marketing spend intentionally paced ahead of Q4 platform expansions
“In healthcare, whoever owns the customer relationship wins, and that's exactly what we're building toward at Hims & Hers. Today, customers want real choice, real value, and a care team that knows them.”
Hims & Hers CEO, on the earnings call
What Is Hims & Hers's Outlook?
For Q4 2026, the company expects revenue of $875 million to $895 million and Adjusted EBITDA of $70 million to $90 million (8% to 10% margin). For full year 2026, it tightened revenue guidance to $3.13 billion to $3.15 billion and reduced Adjusted EBITDA guidance to $257 million to $277 million (8% to 9% margin). Management said it intentionally paced marketing spend ahead of several platform expansions planned for Q4, which it expects will set the company up well heading into 2027.
HIMS YoY Financials
| Metric | Q3 2026 | Q3 2025 | Year over year |
|---|---|---|---|
| Revenue | $890.4M | $599.0M | +48.7% |
| Gross Profit | $509.2M | $442.1M | +15.2% |
HIMS Revenue by Segment
HIMS Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.